Concepedia

Phillip Madonia

PM

4

Publications

472

Citations

4

H-Index

2010

Active since

Affiliations

University of Washington(Current)

UNSW Sydney

The University of Sydney

University of Minnesota Medical Center

Concord Repatriation General Hospital

Phillip Madonia is an author at University of Washington specializing in medicine, chronic kidney disease, and nephrology.

Top concepts

Publications per year

2010–2023

4

Publications

4

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

, , +9

Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT

Matthew S. Shotwell, Ross Nesbitt, Phillip Madonia et al. · Clinical Journal of the American Society of Nephrology · 2016 · 27 citations · Full text

Laboratory Markers as Predictors of Mortality in Patients with Clostridium difficile Infection

Chaitanya Pant, Phillip Madonia, Anil Minocha et al. · Journal of Investigative Medicine · 2010 · 18 citations

, , +16

Rows per page

1–4 of 4